Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and gentamicin sulfate

moxifloxacin has been researched along with gentamicin sulfate in 14 studies

Compound Research Comparison

Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010)
(moxifloxacin)		Studies
(gentamicin sulfate)		Trials
(gentamicin sulfate)		Recent Studies (post-2010) (gentamicin sulfate)
3,1575521,690384292

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)gentamicin sulfate (IC50)
30S ribosomal protein S6Escherichia coli K-120.028
30S ribosomal protein S7Escherichia coli K-120.028
50S ribosomal protein L15Escherichia coli K-120.028
50S ribosomal protein L10Escherichia coli K-120.028
50S ribosomal protein L11Escherichia coli K-120.028
50S ribosomal protein L7/L12Escherichia coli K-120.028
50S ribosomal protein L19Escherichia coli K-120.028
50S ribosomal protein L1Escherichia coli K-120.028
50S ribosomal protein L20Escherichia coli K-120.028
50S ribosomal protein L27Escherichia coli K-120.028
50S ribosomal protein L28Escherichia coli K-120.028
50S ribosomal protein L29Escherichia coli K-120.028
50S ribosomal protein L31Escherichia coli K-120.028
50S ribosomal protein L31 type BEscherichia coli K-120.028
50S ribosomal protein L32Escherichia coli K-120.028
50S ribosomal protein L33Escherichia coli K-120.028
50S ribosomal protein L34Escherichia coli K-120.028
50S ribosomal protein L35Escherichia coli K-120.028
50S ribosomal protein L36Escherichia coli K-120.028
30S ribosomal protein S10Escherichia coli K-120.028
30S ribosomal protein S11Escherichia coli K-120.028
30S ribosomal protein S12Escherichia coli K-120.028
30S ribosomal protein S13Escherichia coli K-120.028
30S ribosomal protein S16Escherichia coli K-120.028
30S ribosomal protein S18Escherichia coli K-120.028
30S ribosomal protein S19Escherichia coli K-120.028
30S ribosomal protein S20Escherichia coli K-120.028
30S ribosomal protein S2Escherichia coli K-120.028
30S ribosomal protein S3Escherichia coli K-120.028
30S ribosomal protein S4Escherichia coli K-120.028
30S ribosomal protein S5Escherichia coli K-120.028
30S ribosomal protein S8Escherichia coli K-120.028
30S ribosomal protein S9Escherichia coli K-120.028
50S ribosomal protein L13Escherichia coli K-120.028
50S ribosomal protein L14Escherichia coli K-120.028
50S ribosomal protein L16Escherichia coli K-120.028
50S ribosomal protein L23Escherichia coli K-120.028
30S ribosomal protein S15Escherichia coli K-120.028
50S ribosomal protein L17Escherichia coli K-120.028
50S ribosomal protein L21Escherichia coli K-120.028
50S ribosomal protein L30Escherichia coli K-120.028
50S ribosomal protein L6Escherichia coli K-120.028
30S ribosomal protein S14Escherichia coli K-120.028
30S ribosomal protein S17Escherichia coli K-120.028
30S ribosomal protein S1Escherichia coli K-120.028
50S ribosomal protein L18Escherichia coli K-120.028
50S ribosomal protein L2Escherichia coli K-120.028
50S ribosomal protein L3Escherichia coli K-120.028
50S ribosomal protein L24Escherichia coli K-120.028
50S ribosomal protein L4Escherichia coli K-120.028
50S ribosomal protein L22Escherichia coli K-120.028
50S ribosomal protein L5Escherichia coli K-120.028
30S ribosomal protein S21Escherichia coli K-120.028
50S ribosomal protein L25Escherichia coli K-120.028
50S ribosomal protein L36 2Escherichia coli K-120.028

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (57.14)29.6817
2010's6 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duewelhenke, N; Eysel, P; Krut, O1
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG1
Lombardo, F; Obach, RS; Waters, NJ1
Cattoir, V; Nordmann, P; Poirel, L1
Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A1
Choi, SH; Jeong, JY; Jun, JB; Kim, ES; Kim, MN; Kim, YS; Lee, SO; Woo, JH1
Chlipala, G; Krunic, A; Mo, S; Orjala, J1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H1
Chen, L; Franzblau, SG; Liu, X; Lu, X; Wan, B; You, Q; Zhou, C1

Other Studies

14 other study(ies) available for moxifloxacin and gentamicin sulfate

ArticleYear
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors

2007
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids

2008
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine

2009
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Acetyltransferases; beta-Lactamases; Ciprofloxacin; Conjugation, Genetic; Enterobacteriaceae; Microbial Sensitivity Tests; Plasmids

2009
Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua.
    Journal of natural products, 2009, May-22, Volume: 72, Issue:5

    Topics: Anti-Bacterial Agents; Bacillus anthracis; Cyanobacteria; Indole Alkaloids; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare

2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction

2010
Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
    European journal of medicinal chemistry, 2012, Volume: 49

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazoles; Thiazoles; Tuberculosis

2012